drospirenone and ethinyl estradiol combination has been researched along with Thromboembolism, Venous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bester, J; de Lange-Loots, Z; Swanepoel, AC | 1 |
| Shapiro, S | 1 |
| Botzenhardt, S; Gratzki, N; Neubert, A; Rascher, W; Toni, I | 1 |
| Botzenhardt, S; Neubert, A; Rascher, W; Toni, I | 1 |
| Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A | 1 |
| Contreras, MT; Laiz, B; López, M; Martínez Triguero, ML; Ricart, A; Todolí, J; Vayá, A | 1 |
| Ribowsky, JH | 1 |
| Burke, AE; Espey, E; Raymond, EG | 1 |
| Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
3 review(s) available for drospirenone and ethinyl estradiol combination and Thromboembolism, Venous
| Article | Year |
|---|---|
Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports.
Topics: Adolescent; Androstenes; Cross-Sectional Studies; Ethinyl Estradiol; Female; Humans; Incidence; Odds Ratio; Proportional Hazards Models; Reproductive Control Agents; Risk; Venous Thromboembolism | 2013 |
[Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
Topics: Adolescent; Androstenes; Child; Cross-Sectional Studies; Ethinyl Estradiol; Female; Humans; Incidence; Reproductive Control Agents; Risk; Venous Thromboembolism; Young Adult | 2013 |
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism | 2015 |
6 other study(ies) available for drospirenone and ethinyl estradiol combination and Thromboembolism, Venous
| Article | Year |
|---|---|
Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users.
Topics: Adolescent; Adult; Androstenes; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fibrin; Humans; Male; Microscopy, Electron, Scanning; Thrombelastography; Thrombosis; Venous Thromboembolism; Viscosity; Young Adult | 2020 |
Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases.
Topics: Androstenes; Bias; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Data Interpretation, Statistical; Databases, Factual; Ethinyl Estradiol; Female; Humans; Risk Factors; Thromboembolism; Venous Thromboembolism | 2013 |
Yasmin and venous thromboembolism: new case reports.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Humans; Prothrombin; Risk Factors; Venous Thromboembolism; Young Adult | 2009 |
Do drospirenone-containing oral contraceptives have a higher risk of VTE?
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Venous Thromboembolism | 2011 |
Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Topics: Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Labeling; Ethinyl Estradiol; Female; Humans; Norgestrel; Risk Assessment; Venous Thromboembolism | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |